| |
| |
|
| Insider
Information: |
Hooper Anthony C |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
618,962 |
|
|
Indirect Shares
|
5,248 |
|
|
| Direct
Value |
$80,812,925 |
|
|
|
Indirect Value
|
$234,638 |
|
|
| Total
Shares |
624,210 |
|
|
| Total
Value |
$81,047,563 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 58.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP ComOps Pres USJap ... |
2011-05-13 |
203,170 |
2011-05-13 |
5,248 |
Premium* |
|
|
Amgen Inc |
AMGN |
EVP, Global Commercial... |
2018-05-03 |
215,147 |
2011-10-27 |
0 |
Premium* |
|
|
MannKind Corp |
MNKD |
Director |
2024-02-04 |
176,153 |
|
0 |
Premium* |
|
|
Beigene Ltd |
BGNE |
Director |
2022-06-22 |
24,492 |
2021-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• – – |
2011-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
45,238 |
45,238 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• – – |
2012-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,654 |
67,227 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2013-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,477 |
74,821 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2013-03-02 |
4 |
D |
$92.58 |
$647,875 |
D/D |
(6,998) |
67,823 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
52,777 |
120,600 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2013-03-13 |
4 |
D |
$91.75 |
$2,526,795 |
D/D |
(27,540) |
93,060 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,044 |
98,402 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2014-03-02 |
4 |
D |
$124.02 |
$934,739 |
D/D |
(7,537) |
90,865 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
52,777 |
143,642 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2014-03-12 |
4 |
D |
$124.27 |
$3,422,396 |
D/D |
(27,540) |
116,210 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2014-04-27 |
4 |
D |
$111.41 |
$172,240 |
D/D |
(1,546) |
114,664 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2015-01-28 |
4 |
D |
$158.89 |
$152,376 |
D/D |
(959) |
113,952 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2015-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,597 |
118,549 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2015-03-02 |
4 |
D |
$157.72 |
$507,070 |
D/D |
(3,215) |
115,334 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
107,354 |
222,688 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2015-03-11 |
4 |
D |
$153.58 |
$4,229,593 |
D/D |
(27,540) |
195,148 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2015-03-27 |
4 |
D |
$160.55 |
$4,595,583 |
D/D |
(28,624) |
166,909 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2015-04-27 |
4 |
D |
$167.91 |
$264,458 |
D/D |
(1,575) |
165,334 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2016-01-28 |
4 |
D |
$150.47 |
$149,718 |
D/D |
(995) |
164,339 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2016-01-31 |
4 |
D |
$152.73 |
$99,427 |
D/D |
(651) |
163,962 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
45,268 |
209,230 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2016-03-25 |
4 |
D |
$149.24 |
$3,549,673 |
D/D |
(23,785) |
185,855 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2016-04-27 |
4 |
D |
$162.85 |
$270,168 |
D/D |
(1,659) |
184,196 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,116 |
189,312 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP, Global Commercial Ops. |
• • – |
2017-01-28 |
4 |
D |
$157.16 |
$165,489 |
D/D |
(1,053) |
188,571 |
0 |
- |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
